Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Eco-friendly info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Industry Programme
Acknowledgements
CME Accreditation
UEG Week on-demand
Congress Resources
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Projects
Research Prize
Research Fellowship
Research Webinars
Advocacy
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
Guideline development framework
Guideline development course
Get Funding
Get Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
Digestive Health Month
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Application Support
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Iris Dotan
EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL
What I regretted most in IBD treatment
Iris Dotan
SEROLOGIC RESPONSE AND SAFETY AFTER THIRD DOSE OF THE COVID-19 BNT162B2 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL
Iris Dotan
et al.
CANNABIS INDUCES SIGNIFICANT CLINICAL AND QOL IMPROVEMENT IN CHRONIC POUCHITIS
Iris Dotan
et al.
THE RISK FOR ADVANCED NEOPLASIA AFTER POLYPECTOMY OF UP TO TWO DIMINUTIVE POLYPS WITH LOW GRADE DYSPLASIA VS. NORMAL COLONOSCOPY
Iris Dotan
et al.
RATE OF INAPPROPRIATE PROTON PUMP INHIBITORS PRESCRIPTION AT DISCHARGE FROM INTERNAL MEDICINE DEPARTMENTS ACCORDING TO A DEVELOPED ALGORITHM
Iris Dotan
et al.
PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE
Iris Dotan
et al.
RESPONSIVENESS OF FECAL CALPROTECTIN AND QUALITY OF LIFE QUESTIONNAIRES TO CHANGE IN POUCH DISEASE ACTIVITY. RESULTS FROM A PROSPECTIVE TRIAL
Iris Dotan
et al.
ROLE OF MAFB TRANSCRIPTION FACTOR IN HUMAN INTESTINAL METAPLASIA AND GASTRIC CANCER BIOPSIES
Iris Dotan
et al.
PERI-PARTUM INFECTIONS AMONG WOMEN WITH INFLAMMATORY BOWEL DISEASE
Iris Dotan
et al.
ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME
Iris Dotan
et al.
MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES
Iris Dotan
et al.
BENEFIT–RISK ASSESSMENT OF UPADACITINIB TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Iris Dotan
et al.
A SIMPLE WEB-BASED TOOL FOR PREDICTING DRUG SUSTAINABILITY OF INFLIXIMAB AND VEDOLIZUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS USING EXPLAINABLE ARTIFICIAL INTELLIGENCE
Iris Dotan
et al.
REDUCED TREATMENT ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIABETES MELLITUS USING NEWER ANTI-DIABETIC MEDICATIONS: AN ANALYSIS FROM THE EPI-IIRN
Iris Dotan
et al.
A GLOBAL CONSENSUS ON THE DEFINITIONS, DIAGNOSIS AND MANAGEMENT OF FIBROSTENOSING SMALL BOWEL CROHN'S DISEASE
Iris Dotan
et al.
MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES (IBD)
Iris Dotan
et al.
MORTALITY IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES – A POPULATION-BASED STUDY FROM THE EPIDEMIOLOGICAL DATABASE OF THE ISRAELI IBD RESEARCH NUCLEUS (EPI-IIRN)
Iris Dotan
et al.
ASSOCIATION OF ANTIBIOTIC USE WITH DURABILITY OF BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE: A REPORT FROM THE EPI-IIRN
Iris Dotan
et al.
Item 1 - 20 / 31
1
2
Chat with us
, powered by
LiveChat